Mode
Text Size
Log in / Sign up

Migrated pancreaticojejunal stents may act as chronic local irritants potentially linked to metachronous cholangiocarcinomaMigrated Surgical Stent Linked to Late Cancer Diagnosis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that indwelling migrated stents may act as chronic irritants potentially linked to late-onset biliary tract malignancies.

This case report describes a 62-year-old male who developed metachronous hilar cholangiocarcinoma (Klatskin tumor) 9 years after a pancreaticoduodenectomy for ampullary adenoma. Intraoperative exploration identified that an internal pancreaticojejunostomy stent had migrated to a site adjacent to the biliary-enteric anastomosis.

Immunohistochemical analysis of the tumor showed wild-type P53 and proficient mismatch repair. The authors hypothesize that the migrated, indwelling stent may have served as a chronic local irritant contributing to carcinogenesis. However, this link is not established as a definitive cause due to the limited scope of the report.

The case highlights the potential risks associated with indwelling surgical stents in the biliary tract and underscores the importance of considering second primary malignancies in patients presenting with late-onset biliary obstruction following pancreaticoduodenectomy. The evidence for a causal link between stent migration and malignancy is low, as it is based on a single patient.

How this fits prior evidence

This case report addresses a gap regarding potential mechanical triggers for secondary malignancies in post-surgical patients. While prior coverage discussed immunotherapy strategies for cholangiocarcinoma and KMT2C alterations in gastrointestinal cancers, this report focuses on the local impact of surgical hardware as a potential irritant for metachronous tumors.

Doctors reported on a 62-year-old man who had surgery for an ampullary adenoma nine years ago. During a later procedure for jaundice, surgeons found a piece of equipment called a pancreaticojejunal stent that had moved from its original spot. This migrated stent was located near a different surgical connection.

Tests confirmed the patient had developed a type of bile duct cancer known as a Klatskin tumor. Because this cancer appeared years after his first surgery, doctors are looking into why it developed in that specific location. The study notes that while the link is not proven, the old stent may have caused long-term irritation to the nearby tissue.

This report highlights a potential risk for patients who have had internal stents placed during past surgeries. Because this was a single case, it does not prove that all stents cause cancer. However, it reminds doctors to check for both migrated hardware and secondary cancers when a patient develops new issues in the bile duct area.

What this means for you:
A single case suggests that old, moved surgical stents may be linked to later cancer development.

Common questions

Can an old surgical stent cause cancer?

This specific case study shows a link between a migrated pancreaticojejunal stent and the development of a Klatskin tumor. While it does not prove that all stents cause cancer, the researchers suggest that indwelling hardware can act as a chronic local irritant over many years.

What happened to the patient in this study?

A 62-year-old man was found to have a migrated stent nine years after his initial surgery. The stent had moved to a site near his biliary-enteric anastomosis. He was later diagnosed with poorly differentiated cholangiocarcinoma, which caused obstructed jaundice.

Is this finding common for other patients?

Because this is a single case report involving only one patient, the findings cannot be generalized to everyone. It serves as a warning for doctors to consider both moved hardware and second primary malignancies when treating patients with late-onset biliary obstruction.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Metachronous cholangiocarcinoma following curative surgery for periampullary neoplasia is a rare but serious long-term complication that poses significant diagnostic and management challenges. We report the case of a 62-year-old male who developed hilar cholangiocarcinoma 9 years after undergoing a pancreaticoduodenectomy (Whipple procedure) for an ampullary adenoma. The patient was initially diagnosed with a duodenal papillary villous tubular adenoma showing moderate dysplasia in 2015 and underwent curative resection, with no evidence of recurrence during subsequent follow-up. In 2024, he presented with obstructive jaundice and imaging findings revealing a hepatic hilar mass with intrahepatic biliary dilation. A biopsy confirmed a poorly differentiated cholangiocarcinoma (Klatskin tumor). Crucially, intraoperative exploration identified migration of the internal pancreaticojejunostomy stent to a site adjacent to the biliary-enteric anastomosis. Immunohistochemical analysis demonstrated wild-type P53 expression and proficient mismatch repair function, supporting a sporadic rather than hereditary origin. This case underscores the importance of considering second primary malignancies in patients with late-onset biliary obstruction after pancreaticoduodenectomy. We propose that the migrated and retained pancreatic stent may have acted as a chronic local irritant, potentially exacerbating inflammation and contributing to carcinogenesis within the biliary-enteric anastomotic milieu, thereby highlighting a possible long-term risk associated with indwelling surgical stents.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.